Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Arrhythmias

Free Subscription Articles published in J Cardiovasc Pharmacol Retrieve available abstracts of 27 articles: HTML format Text format

Single Articles

October 2011
1. BESANA A , Wang DW, George AL Jr, Schwartz PJ, et al
   Nadolol block of Nav1.5 does not explain its efficacy in the long QT syndrome.
   J Cardiovasc Pharmacol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   June 2011
2. DESHMUKH PA , Bellary SR, Schwender FT, Kamalov G, et al
   SPIRONOLACTONE PREVENTS THE INDUCIBILITY OF VENTRICULAR TACHYARRHYTHMIA IN RATS WITH ALDOSTERONISM.
   J Cardiovasc Pharmacol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. TAN AY , Zimetbaum P
   Atrial fibrillation and atrial fibrosis.
   J Cardiovasc Pharmacol. 2011;57:625-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. DE JONG S , van Veen TA, van Rijen HV, de Bakker JM, et al
   Fibrosis and cardiac arrhythmias.
   J Cardiovasc Pharmacol. 2011;57:630-8.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   May 2011
5. CHAN HT , So LT, Li SW, Siu CW, et al
   Effect of Herbal Consumption on Time in Therapeutic Range of Warfarin Therapy in Patients with Atrial Fibrillation.
   J Cardiovasc Pharmacol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. HONDEGHEM LM , Dujardin K, Hoffmann P, Dumotier B, et al
   Drug-induced QTC prolongation dangerously underestimates proarrhythmic potential: lessons from terfenadine.
   J Cardiovasc Pharmacol. 2011;57:589-97.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   April 2011
7. LIEU PB , Fornari M, Ramos T, Hatcher AS, et al
   Reduced antiarrhythmic efficacy of verapamil in isolated rat hearts in the presence of elevated extracellular calcium.
   J Cardiovasc Pharmacol. 2011;57:455-62.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. VASQUEZ C , Benamer N, Morley GE
   The cardiac fibroblast: functional and electrophysiological considerations in healthy and diseased hearts.
   J Cardiovasc Pharmacol. 2011;57:380-8.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   March 2011
9. LEE YM , Cheng PY, Chen SY, Chung MT, et al
   Wogonin Suppresses Arrhythmias, Inflammatory Responses and Apoptosis Induced by Myocardial Ischemia/Reperfusion in Rats.
   J Cardiovasc Pharmacol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. SKIBSBYE L , Diness JG, Sorensen US, Hansen RS, et al
    The duration of pacing induced atrial fibrillation is reduced in vivo by inhibition of Small Conductance Ca2+ activated K+ Channels.
    J Cardiovasc Pharmacol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
11. HATCHER AS , Alderson JM, Clements-Jewery H
    CARDIAC Mitochondrial uncoupling agents trigger ventricular fibrillation in isolated rat hearts.
    J Cardiovasc Pharmacol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
12. TAN AY , Zimetbaum P
    Atrial Fibrillation and Atrial Fibrosis.
    J Cardiovasc Pharmacol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
13. WANG Z
    The role of microRNA in cardiac excitability.
    J Cardiovasc Pharmacol. 2010;56:460-70.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
14. BALIJEPALLI SY , Anderson CL, Lin EC, January CT, et al
    Rescue of mutated cardiac ion channels in inherited arrhythmia syndromes.
    J Cardiovasc Pharmacol. 2010;56:113-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. YANG PC , Clancy CE
    Effects of sex hormones on cardiac repolarization.
    J Cardiovasc Pharmacol. 2010;56:123-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
16. BAKKER ML , Christoffels VM, Moorman AF
    The cardiac pacemaker and conduction system develops from embryonic myocardium that retains its primitive phenotype.
    J Cardiovasc Pharmacol. 2010;56:6-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. LAZZARA R
    The right stuff in the right place-the quest for atrial selective antiarrhythmic agents.
    J Cardiovasc Pharmacol. 2010;56:78-9.
    PubMed     Text format     Related articles   
    
    
    
    
18. PELLEG A , Belhassen B
    The mechanism of the negative chronotropic and dromotropic actions of adenosine 5'-triphosphate in the heart: an update.
    J Cardiovasc Pharmacol. 2010;56:106-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. ZORNIAK M , Mitrega K, Bialka S, Porc M, et al
    Comparison of thiopental, urethane, and pentobarbital in the study of experimental cardiology in rats in vivo.
    J Cardiovasc Pharmacol. 2010;56:38-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
20. DE ARAUJO-JUNIOR JX , Julien C, Barres C, de Medeiros IA, et al
    Cardiovascular Effects of a Novel Synthetic Analogue of Naturally Occurring Piperamides.
    J Cardiovasc Pharmacol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. VERRIER RL , Nieminen T
    T-wave alternans as a therapeutic marker for antiarrhythmic agents.
    J Cardiovasc Pharmacol. 2010;55:544-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. SCHWARTZ PJ , Stramba-Badiale M
    Repolarization abnormalities in the newborn.
    J Cardiovasc Pharmacol. 2010;55:539-43.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. BAUER A , Zurn CS, Schmidt G
    Heart rate turbulence to guide treatment for prevention of sudden death.
    J Cardiovasc Pharmacol. 2010;55:531-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
24. DAS MK , Zipes DP
    Antiarrhythmic and nonantiarrhythmic drugs for sudden cardiac death prevention.
    J Cardiovasc Pharmacol. 2010;55:438-49.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. VERRIER RL , Josephson ME
    Noninvasive arrhythmia risk assessment in guiding pharmacologic therapy for prevention of sudden cardiac death: where do we stand? Where do we go?
    J Cardiovasc Pharmacol. 2010;55:425-7.
    PubMed     Text format     Related articles   
    
    
    
    
26. ROSEN MR , Janse MJ
    Concept of the vulnerable parameter: the Sicilian Gambit revisited.
    J Cardiovasc Pharmacol. 2010;55:428-37.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2010
27. JING H , Luo L, Li H, Sun J, et al
    Ephedrine controls heart rhythms by activating cardiac I(ks) currents.
    J Cardiovasc Pharmacol. 2010;55:145-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: